165 related articles for article (PubMed ID: 16007223)
1. The merlin tumor suppressor interacts with Ral guanine nucleotide dissociation stimulator and inhibits its activity.
Ryu CH; Kim SW; Lee KH; Lee JY; Kim H; Lee WK; Choi BH; Lim Y; Kim YH; Lee KH; Hwang TK; Jun TY; Rha HK
Oncogene; 2005 Aug; 24(34):5355-64. PubMed ID: 16007223
[TBL] [Abstract][Full Text] [Related]
2. MAP, a protein interacting with a tumor suppressor, merlin, through the run domain.
Lee IK; Kim KS; Kim H; Lee JY; Ryu CH; Chun HJ; Lee KU; Lim Y; Kim YH; Huh PW; Lee KH; Han SI; Jun TY; Rha HK
Biochem Biophys Res Commun; 2004 Dec; 325(3):774-83. PubMed ID: 15541357
[TBL] [Abstract][Full Text] [Related]
3. Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation.
Matsubara K; Kishida S; Matsuura Y; Kitayama H; Noda M; Kikuchi A
Oncogene; 1999 Feb; 18(6):1303-12. PubMed ID: 10022812
[TBL] [Abstract][Full Text] [Related]
4. Oog1, an oocyte-specific protein, interacts with Ras and Ras-signaling proteins during early embryogenesis.
Tsukamoto S; Ihara R; Aizawa A; Kishida S; Kikuchi A; Imai H; Minami N
Biochem Biophys Res Commun; 2006 May; 343(4):1105-12. PubMed ID: 16580637
[TBL] [Abstract][Full Text] [Related]
5. Merlin inhibits growth hormone-regulated Raf-ERKs pathways by binding to Grb2 protein.
Lim JY; Kim H; Jeun SS; Kang SG; Lee KJ
Biochem Biophys Res Commun; 2006 Feb; 340(4):1151-7. PubMed ID: 16405865
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.
Muranen T; Grönholm M; Lampin A; Lallemand D; Zhao F; Giovannini M; Carpén O
Hum Mol Genet; 2007 Jul; 16(14):1742-51. PubMed ID: 17566081
[TBL] [Abstract][Full Text] [Related]
7. Identification of Rgl3 as a potential binding partner for Rap-family small G-proteins and profilin II.
Xu J; Shi S; Matsumoto N; Noda M; Kitayama H
Cell Signal; 2007 Jul; 19(7):1575-82. PubMed ID: 17382517
[TBL] [Abstract][Full Text] [Related]
8. Colocalization of Ras and Ral on the membrane is required for Ras-dependent Ral activation through Ral GDP dissociation stimulator.
Kishida S; Koyama S; Matsubara K; Kishida M; Matsuura Y; Kikuchi A
Oncogene; 1997 Dec; 15(24):2899-907. PubMed ID: 9416833
[TBL] [Abstract][Full Text] [Related]
9. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
10. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P
Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759
[TBL] [Abstract][Full Text] [Related]
11. RalGDS is required for tumor formation in a model of skin carcinogenesis.
González-García A; Pritchard CA; Paterson HF; Mavria G; Stamp G; Marshall CJ
Cancer Cell; 2005 Mar; 7(3):219-26. PubMed ID: 15766660
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
Scoles DR; Huynh DP; Morcos PA; Coulsell ER; Robinson NG; Tamanoi F; Pulst SM
Nat Genet; 1998 Apr; 18(4):354-9. PubMed ID: 9537418
[TBL] [Abstract][Full Text] [Related]
13. Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.
Chen Y; Gutmann DH; Haipek CA; Martinsen BJ; Bronner-Fraser M; Krull CE
Dev Dyn; 2004 Mar; 229(3):541-54. PubMed ID: 14991710
[TBL] [Abstract][Full Text] [Related]
14. The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.
Jung JR; Kim H; Jeun SS; Lee JY; Koh EJ; Ji C
Mol Cells; 2005 Oct; 20(2):196-200. PubMed ID: 16267393
[TBL] [Abstract][Full Text] [Related]
15. Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.
Johnson KC; Kissil JL; Fry JL; Jacks T
Oncogene; 2002 Sep; 21(39):5990-7. PubMed ID: 12203111
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
Yamauchi J; Miyamoto Y; Kusakawa S; Torii T; Mizutani R; Sanbe A; Nakajima H; Kiyokawa N; Tanoue A
Exp Cell Res; 2008 Jul; 314(11-12):2279-88. PubMed ID: 18486129
[TBL] [Abstract][Full Text] [Related]
17. Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).
Scoles DR; Yong WH; Qin Y; Wawrowsky K; Pulst SM
Hum Mol Genet; 2006 Apr; 15(7):1059-70. PubMed ID: 16497727
[TBL] [Abstract][Full Text] [Related]
18. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
[TBL] [Abstract][Full Text] [Related]
19. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
[TBL] [Abstract][Full Text] [Related]
20. The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor.
López-Barahona M; Bustelo XR; Barbacid M
Oncogene; 1996 Feb; 12(3):463-70. PubMed ID: 8637701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
